Pretreatment with nebivolol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischaemia-reperfusion injury

ERSAN S., TANRISEV M., Cavdar Z., Celik A., Unlu M., Kocak A., ...Daha Fazla

NEPHROLOGY, cilt.22, ss.1023-1029, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 22 Konu: 12
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1111/nep.13007
  • Dergi Adı: NEPHROLOGY
  • Sayfa Sayıları: ss.1023-1029


AimMatrix metalloproteinases (MMPs) are zinc-containing proteinases that are involved in the degradation of extracellular matrix (ECM) and a number of cell surface proteins in order to maintain tissue homeostasis. They are involved in pathogenesis of several ischaemic organ injuries. In the present study, we aimed to determine the expression and level of MMP-2 and MMP-9 in renal ischaemia-reperfusion injury (IRI) model and the potential beneficial effect of nebivolol, a (1)-adrenergic receptor blocker, on both MMP-2 and -9 level and expression and tubular injury caused by IRI.